Trial site
Buenos Aires
- 23running trials
- 4closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)5 trials
- COPD5 trials
- Asthma3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Multiple sclerosis2 trials
- Ulcerative colitis2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Graves' disease1 trial
- Hidradenitis suppurativa1 trial
- Lupus (SLE)1 trial
- Multiple myeloma1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 315 trials
- Phase 28 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Active, not recruiting15 trials
- Recruiting7 trials
- Completed4 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi27 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Active, not recruiting
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD3 recruiting
- Asthma1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Graves' disease1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026